29 September 2023
Frontier IP Group plc
("Frontier IP" or the "Company")
Total Voting Rights
Frontier IP, a specialist in commercialising intellectual property, announces that the issued share capital of the Company at the date of this announcement comprises 55,734,553 ordinary shares of 10 pence each with one voting right per share ('Ordinary Shares'). The Company does not hold any Ordinary Shares in treasury. The total number of Ordinary Shares and voting rights in the Company is therefore 55,734,553.
The above figure of 55,734,553 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
ENQUIRIES
Frontier IP Group Plc | T: 020 3968 7815 |
Neil Crabb, Chief Executive Andrew Johnson, Communications & Investor Relations Company website: www.frontierip.co.uk
| neil@frontierip.co.uk M: 07464 546 025 |
Allenby Capital Limited (Nominated Adviser) Nick Athanas / George Payne
| T: 0203 328 5656 |
Singer Capital Markets (Broker) Harry Gooden / James Fischer
| T: 0207 496 3000 |
ABOUT FRONTIER IP
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.